321 related articles for article (PubMed ID: 26972830)
1. Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways.
Ryczko MC; Pawling J; Chen R; Abdel Rahman AM; Yau K; Copeland JK; Zhang C; Surendra A; Guttman DS; Figeys D; Dennis JW
Sci Rep; 2016 Mar; 6():23043. PubMed ID: 26972830
[TBL] [Abstract][Full Text] [Related]
2. Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.
Abdel Rahman AM; Ryczko M; Nakano M; Pawling J; Rodrigues T; Johswich A; Taniguchi N; Dennis JW
Glycobiology; 2015 Feb; 25(2):225-40. PubMed ID: 25395405
[TBL] [Abstract][Full Text] [Related]
3. N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway.
Johswich A; Longuet C; Pawling J; Abdel Rahman A; Ryczko M; Drucker DJ; Dennis JW
J Biol Chem; 2014 Jun; 289(23):15927-41. PubMed ID: 24742675
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching.
Chen HL; Li CF; Grigorian A; Tian W; Demetriou M
J Biol Chem; 2009 Nov; 284(47):32454-61. PubMed ID: 19706602
[TBL] [Abstract][Full Text] [Related]
5. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry.
Abdel Rahman AM; Ryczko M; Pawling J; Dennis JW
ACS Chem Biol; 2013 Sep; 8(9):2053-62. PubMed ID: 23875632
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of GlcNAc-rich
Szulc B; Sosicka P; Maszczak-Seneczko D; Skurska E; Shauchuk A; Olczak T; Freeze HH; Olczak M
J Biol Chem; 2020 Nov; 295(48):16445-16463. PubMed ID: 32938718
[TBL] [Abstract][Full Text] [Related]
7. Complex N-glycan and metabolic control in tumor cells.
Mendelsohn R; Cheung P; Berger L; Partridge E; Lau K; Datti A; Pawling J; Dennis JW
Cancer Res; 2007 Oct; 67(20):9771-80. PubMed ID: 17942907
[TBL] [Abstract][Full Text] [Related]
8. Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.
Lee SU; Li CF; Mortales CL; Pawling J; Dennis JW; Grigorian A; Demetriou M
PLoS One; 2019; 14(3):e0214253. PubMed ID: 30913278
[TBL] [Abstract][Full Text] [Related]
9. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
10. Hexosamine biosynthesis in keratinocytes: roles of GFAT and GNPDA enzymes in the maintenance of UDP-GlcNAc content and hyaluronan synthesis.
Oikari S; Makkonen K; Deen AJ; Tyni I; Kärnä R; Tammi RH; Tammi MI
Glycobiology; 2016 Jul; 26(7):710-22. PubMed ID: 26887390
[TBL] [Abstract][Full Text] [Related]
11. Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis.
Grigorian A; Lee SU; Tian W; Chen IJ; Gao G; Mendelsohn R; Dennis JW; Demetriou M
J Biol Chem; 2007 Jul; 282(27):20027-35. PubMed ID: 17488719
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Direct Biosynthetic Pathway for UDP-
Dadashipour M; Iwamoto M; Hossain MM; Akutsu JI; Zhang Z; Kawarabayasi Y
J Bacteriol; 2018 May; 200(10):. PubMed ID: 29507091
[TBL] [Abstract][Full Text] [Related]
13. Adaptive regulation at the cell surface by N-glycosylation.
Dennis JW; Lau KS; Demetriou M; Nabi IR
Traffic; 2009 Nov; 10(11):1569-78. PubMed ID: 19761541
[TBL] [Abstract][Full Text] [Related]
14. A method to the madness of N-glycan complexity?
Stanley P
Cell; 2007 Apr; 129(1):27-9. PubMed ID: 17418781
[TBL] [Abstract][Full Text] [Related]
15. Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L
J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789
[TBL] [Abstract][Full Text] [Related]
16. Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes: a comparison of UDP-hexosamine levels after increased glucose flux and glucosamine treatment.
Bosch RR; Pouwels MJ; Span PN; Olthaar AJ; Tack CJ; Hermus AR; Sweep CG
Endocrine; 2004 Feb; 23(1):17-24. PubMed ID: 15034192
[TBL] [Abstract][Full Text] [Related]
17. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme-multi-transporter assemblies in golgi membranes in vivo.
Khoder-Agha F; Sosicka P; Escriva Conde M; Hassinen A; Glumoff T; Olczak M; Kellokumpu S
Cell Mol Life Sci; 2019 May; 76(9):1821-1832. PubMed ID: 30737517
[TBL] [Abstract][Full Text] [Related]
18. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Swamy M; Pathak S; Grzes KM; Damerow S; Sinclair LV; van Aalten DM; Cantrell DA
Nat Immunol; 2016 Jun; 17(6):712-20. PubMed ID: 27111141
[TBL] [Abstract][Full Text] [Related]
19. N-Glycans in cancer progression.
Lau KS; Dennis JW
Glycobiology; 2008 Oct; 18(10):750-60. PubMed ID: 18701722
[TBL] [Abstract][Full Text] [Related]
20. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
